State Street’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,201
| Closed | -$39K | – | 3842 |
|
|
2019
Q3 | $39K | Hold |
10,201
| – | – | ﹤0.01% | 3734 |
|
|
2019
Q2 | $68K | Sell |
10,201
-97,628
| -91% | -$651K | ﹤0.01% | 3702 |
|
|
2019
Q1 | $383K | Buy |
107,829
+15,778
| +17% | +$56K | ﹤0.01% | 3480 |
|
|
2018
Q4 | $365K | Buy |
92,051
+21,354
| +30% | +$84.7K | ﹤0.01% | 3490 |
|
|
2018
Q3 | $1.4M | Buy |
70,697
+28,201
| +66% | +$556K | ﹤0.01% | 3348 |
|
|
2018
Q2 | $1.35M | Buy |
42,496
+3,962
| +10% | +$126K | ﹤0.01% | 3362 |
|
|
2018
Q1 | $1.43M | Buy |
38,534
+6,237
| +19% | +$231K | ﹤0.01% | 3277 |
|
|
2017
Q4 | $2.55M | Buy |
+32,297
| New | +$2.55M | ﹤0.01% | 3093 |
|